Efficacy Comparison of Dostarlimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)
GlaxoSmithKline
GlaxoSmithKline
NYU Langone Health
University of Kentucky
BeiGene
Wake Forest University Health Sciences
Transgene
Intergroupe Francophone de Cancerologie Thoracique
Abramson Cancer Center at Penn Medicine
Merck KGaA, Darmstadt, Germany
Memorial Sloan Kettering Cancer Center
Pfizer
Hoffmann-La Roche